Atlas Capital Advisors LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Atlas Capital Advisors LLC

  • $640 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$5.12 - $8.19 $5,120 - $8,189
-1,000 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$7.98 - $12.29 $7,980 - $12,290
1,000 New
1,000 $12,000
Q3 2020

Oct 23, 2020
SELL
$7.96 - $12.42 $7,960 - $12,420
-1,000 Closed
0 $0
Q2 2020

Jul 28, 2020
BUY
$5.4 - $13.37 $5,400 - $13,370
1,000 New
1,000 $9,000

Others Institutions Holding EIGR

# of Institutions
6
Shares Held
748K
Call Options Held
0
Put Options Held
0
View Full List

About Eiger BioPharmaceuticals, Inc.

EIGR Quotes by TradingView
  • Ticker EIGR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,966,800
  • Market Cap $496M
  • Description
  • Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...
More about EIGR
Track This Portfolio

Track Atlas Capital Advisors LLC Portfolio

Follow Atlas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email